Pretreatment Brain Connectome Fingerprint Predicts Treatment Response in Major Depressive Disorder

Background Major depressive disorder (MDD) treatment is characterized by low remission rate and often involves weeks to months of treatment. Identification of pretreatment biomarkers of response may play a critical role in novel drug development, in enhanced prognostic predictions, and perhaps in pr...

Full description

Bibliographic Details
Main Authors: Siyan Fan, Samaneh Nemati, Teddy J. Akiki, Jeremy Roscoe, Christopher L. Averill, Samar Fouda, Lynnette A. Averill, Chadi G. Abdallah
Format: Article
Language:English
Published: SAGE Publishing 2020-12-01
Series:Chronic Stress
Online Access:https://doi.org/10.1177/2470547020984726

Similar Items